Related Experiment Video
Updated: May 7, 2026
12:47
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
Published on: May 14, 2012
Clinical therapy using iPSCs: hopes and challenges.
1State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Genomics, Proteomics & Bioinformatics
|September 25, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer regenerative medicine potential by creating patient-specific cells. However, challenges like tumorigenicity must be addressed for safe clinical applications.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Epigenetics
Background:
- Induced pluripotent stem cells (iPSCs) are generated from somatic cells via transcription factor reprogramming.
- iPSCs possess self-renewal and differentiation capabilities akin to embryonic stem cells (ESCs).
- They hold significant promise for autologous cell therapies in regenerative medicine.
Purpose of the Study:
- To review recent advancements in iPSC applications for disease modeling.
- To summarize progress in using iPSCs for clinical treatments.
- To highlight challenges impeding the clinical translation of iPSC technology.
Main Methods:
- Review of current literature on iPSC generation and applications.
- Analysis of studies focusing on disease modeling using iPSCs.
- Examination of clinical trial data and pre-clinical research regarding iPSC therapies.
Main Results:
- iPSCs have shown utility in modeling various genetic and complex diseases.
- Progress has been made in preclinical studies for conditions like macular degeneration and Parkinson's disease.
- Key challenges identified include tumorigenicity, immunogenicity, and genomic instability of iPSCs.
Conclusions:
- iPSC technology is advancing rapidly for disease modeling and potential therapies.
- Addressing safety concerns such as tumorigenicity and immunogenicity is crucial for clinical success.
- Further research is needed to overcome hurdles for widespread iPSC-based regenerative medicine.
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...